Listed

Cumberland Pharmaceuticals Inc

CPIXNasdaqCIK 1087294HealthcareFiscal year ends Dec 31

Reports and events: 327 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Cumberland Pharmaceuticals Inc, Reports and events
FiledFormWhat it isAccession number
2011-01-0617:06 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001299933-11-000095
2010-11-1516:39 ET10-QQuarterly reportPeriod 2010-09-300000950123-10-105751
2010-11-1214:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001299933-10-004049
2010-10-0517:16 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits0000950123-10-091452
2010-08-1617:10 ET10-QQuarterly reportPeriod 2010-06-300000950123-10-078110
2010-08-1616:02 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001299933-10-003092
2010-08-1317:29 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001299933-10-003084
2010-07-2218:55 ET8-K8.01 Other events0001299933-10-002760
2010-05-1715:13 ET10-QQuarterly reportPeriod 2010-03-310000950123-10-050308
2010-05-1415:59 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001299933-10-001970
2010-04-2315:04 ET8-K5.07 Shareholder vote results; 8.01 Other events0001299933-10-001600
2010-04-0612:10 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001299933-10-001373
2010-03-2916:46 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001299933-10-001266
2010-03-2221:11 ETDEF 14AProxy statementPeriod 2010-04-200000950123-10-026559
2010-03-1914:36 ET10-KAnnual reportPeriod 2009-12-310000950123-10-026333
2010-03-1111:07 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001299933-10-001025
2009-11-1217:15 ET10-QQuarterly reportPeriod 2009-09-300000950123-09-061846
2009-11-1017:07 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001299933-09-004491
2009-09-0911:58 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001299933-09-003670
2009-08-3112:32 ET10-QQuarterly reportPeriod 2009-06-300000950123-09-039652
2009-08-2814:19 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001299933-09-003550
2009-07-2915:52 ETS-1/ARegistration statement, amended0000950123-09-026938
2009-07-1717:12 ETS-1/ARegistration statement, amended0000950123-09-023228
2009-05-1216:31 ETS-1/ARegistration statement, amended0000950144-09-004230
2009-04-1017:49 ETS-1/ARegistration statement, amended0000950144-09-003082
2009-03-1817:01 ETS-1/ARegistration statement, amended0000950144-09-002353
2009-02-1817:01 ETS-1/ARegistration statement, amended0000950144-09-001408

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 23:39 ET. Listed shows no prices and gives no investment advice.